Bill > H0367

This bill creates a new law in Florida that caps the cost-sharing requirements for insulin and diabetes supplies for individuals with health insurance. Specifically, the bill defines "cost-sharing requirement" as any out-of-pocket expense like deductibles, copayments, or coinsurance, and applies to all health insurance policies issued or renewed in Florida starting January 1, 2027. The legislation limits insurers from charging more than $35 for a 30-day supply of insulin, regardless of the type or quantity prescribed, and caps the cost of diabetes supplies (such as blood-glucose test strips, glucometers, continuous glucometers, lancets, lancing devices, and insulin syringes) at $100 for a 30-day supply. This bill aims to make diabetes management more affordable by reducing the financial burden on patients who require these essential medical supplies. The provisions will take effect on July 1, 2026, and cover a wide range of health insurance providers, including group, blanket, and franchise health insurers, prepaid health service organizations, and health maintenance organizations.

Health and Social Services

https://www.flsenate.gov/Session/Bill/2026/367